Comparison of the effects of the GPIIb-IIIa antagonist Zalunfiban and the P2Y12 antagonist Selatogrel on Platelet Aggregation

Understanding the pharmacodynamic effects of platelet inhibitors is standard for developing more effective antithrombotic therapies. An example is the antithrombotic treatment of acute coronary syndrome (ACS), in particular ST-elevated myocardial infarction (STEMI) patients who are in need for rapid...

Descripción completa

Detalles Bibliográficos
Autores principales: Curry, Benjamin J., Rikken, A.O.F. Sem, Gibson, C. Michael, Granger, Christopher B., van ‘t Hof, Arnoud W.J., ten Berg, Jurriën M., Jennings, Lisa K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550877/
https://www.ncbi.nlm.nih.gov/pubmed/37563502
http://dx.doi.org/10.1007/s11239-023-02867-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550877/
https://www.ncbi.nlm.nih.gov/pubmed/37563502
http://dx.doi.org/10.1007/s11239-023-02867-x

Ejemplares similares